Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 2:51 pm Purchase | 2022-12-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 2,804,485 5.210% | 2,804,485 (New Position) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BlackRock, Inc. BLK | 3,917,489 7.300% | 641,319 (+19.58%) | Filing History |
| 2022-04-25 7:02 pm Unchanged | 2022-04-25 | 13D | CRINETICS PHARMACEUTICALS INC CRNX | Perceptive Advisors LLC | 5,333,532 10.000% | 0 (Unchanged) | Filing History |
| 2022-04-20 9:17 pm Purchase | 2022-04-18 | 13D | CRINETICS PHARMACEUTICALS INC CRNX | Perceptive Advisors LLC | 5,333,532 10.000% | 1,674,151 (+45.75%) | Filing History |
| 2022-02-14 09:08 am Purchase | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Deep Track Capital, LP | 1,900,000 4.000% | 1,334 (+0.07%) | Filing History |
| 2022-02-11 5:22 pm Sale | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Vivo Capital VIII, LLC | 0 0.000% | -1,819,600 (Position Closed) | Filing History |
| 2022-02-11 4:19 pm Purchase | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | ORBIMED ADVISORS LLC | 3,196,876 6.700% | 443,309 (+16.10%) | Filing History |
| 2022-02-10 8:21 pm Sale | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Versant Venture Capital V, L.P. | 382,961 0.800% | -1,512,041 (-79.79%) | Filing History |
| 2022-02-10 4:30 pm Purchase | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Struthers Richard Scott | 1,978,334 4.200% | 274,339 (+16.10%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BlackRock, Inc. BLK | 3,276,170 6.900% | 1,162,975 (+55.03%) | Filing History |
| 2022-01-10 1:26 pm Sale | 2022-01-07 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 3,722,294 7.836% | -1,216,055 (-24.62%) | Filing History |
| 2022-01-10 11:09 am Purchase | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | DRIEHAUS CAPITAL MANAGEMENT LLC | 4,793,638 10.090% | 4,793,638 (New Position) | Filing History |
| 2021-10-29 4:29 pm Purchase | 2021-10-21 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BIOTECHNOLOGY VALUE FUND L P | 3,003,879 6.500% | 3,003,879 (New Position) | Filing History |